• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周带前列腺癌:组织病理学上的位置及前列腺内扩散模式

Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology.

作者信息

Haffner Jérémie, Potiron Eric, Bouyé Sébastien, Puech Philippe, Leroy Xavier, Lemaitre Laurent, Villers Arnauld

机构信息

Department of Urology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.

出版信息

Prostate. 2009 Feb 15;69(3):276-82. doi: 10.1002/pros.20881.

DOI:10.1002/pros.20881
PMID:19016249
Abstract

BACKGROUND

To describe the precise location of peripheral zone (PZ) prostate cancers at various stages of development and to demonstrate their pattern of intraprostatic spread from their site of origin.

METHODS

PZ cancers defined as cancers located in peripheral zone (PZ) including the anterolateral part of PZ, were identified from radical prostatectomy specimens. PZ cancers morphometric histopathological study included largest surface area, volume and spatial distribution.

RESULTS

Out of 188 PZ cancers, 179 were <4 cm(3) and 168 <2 cm(3). PZ cancers were still confined to their zone of origin for volumes <2 cm(3). Between 2 and 4 cm(3), some cancers partially spread into the transition zone or anterior fibromuscular stroma. Sixty-four and 90% of PZ cancers <4 cm(3) were located in the lower and posterior half of the gland respectively. Ten percent were located in the anterior horn of PZ. Overall, non-index (second) cancers were located in the ipsi and contolateral side of the index cancer (largest) in 31% and 69% of cases, respectively. Cancers <2 cm(3) were confined to one lobe in 164 of 168 (98%) cases and not confined in 3 out of 11 (27%) cancers 2-4 cm(3). On vertical axis, only cancers >or=2 cm(3) involved both apex and base.

CONCLUSIONS

PZ cancers contours and locations are predictable and conform to histological zone boundaries if <2 cm(3) in volume. Knowledge of PZ cancers origin and pattern of spread in PZ are of importance for imaging diagnosis, guidance for biopsy and focal therapy.

摘要

背景

描述外周带(PZ)前列腺癌在不同发展阶段的精确位置,并展示其从起源部位开始的前列腺内扩散模式。

方法

从根治性前列腺切除术标本中识别出定义为位于外周带(PZ)包括PZ前外侧部分的癌症。PZ癌的形态计量组织病理学研究包括最大表面积、体积和空间分布。

结果

在188例PZ癌中,179例体积<4 cm³,168例<2 cm³。体积<2 cm³的PZ癌仍局限于其起源区域。在2至4 cm³之间,一些癌症部分扩散至移行区或前部纤维肌基质。体积<4 cm³的PZ癌分别有64%和90%位于腺体的下半部和后半部。10%位于PZ的前角。总体而言,非索引(第二个)癌分别在31%和69%的病例中位于索引癌(最大)的同侧和对侧。168例体积<2 cm³的癌症中有164例(98%)局限于一个叶,而11例体积为2 - 4 cm³的癌症中有3例(27%)不局限于此。在垂直轴上,只有体积≥2 cm³的癌症同时累及尖部和底部。

结论

如果体积<2 cm³,PZ癌的轮廓和位置是可预测的,并且符合组织学区域边界。了解PZ癌在PZ中的起源和扩散模式对于影像诊断、活检指导和聚焦治疗具有重要意义。

相似文献

1
Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology.外周带前列腺癌:组织病理学上的位置及前列腺内扩散模式
Prostate. 2009 Feb 15;69(3):276-82. doi: 10.1002/pros.20881.
2
Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.移行区和前列腺前基质癌:组织病理学上的起源区域和前列腺内扩散模式
Prostate. 2009 Jan 1;69(1):105-13. doi: 10.1002/pros.20859.
3
Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.前列腺移行区和外周区癌临床病理特征差异分析
Int J Urol. 2006 Apr;13(4):368-72. doi: 10.1111/j.1442-2042.2006.01307.x.
4
Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.临床分期为T1c与T2的前列腺腺癌根治性前列腺切除术的病理参数:病理分期降低及移行区肿瘤检出率增加。
J Urol. 2002 Aug;168(2):519-24.
5
Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?对于血清前列腺特异性抗原>10 ng/ml且先前外周带活检阴性的良性前列腺增生患者,移行区活检是否有价值?
Scand J Urol Nephrol. 2005;39(1):49-55. doi: 10.1080/00365590410002555.
6
Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.动态对比增强盆腔相控阵磁共振成像用于预测局限性前列腺癌的肿瘤体积:与根治性前列腺切除术结果的相关性
J Urol. 2006 Dec;176(6 Pt 1):2432-7. doi: 10.1016/j.juro.2006.08.007.
7
An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.148例连续性移行区癌的分析:临床及组织学特征
J Urol. 2000 Jun;163(6):1751-5.
8
Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients.血清前列腺特异性抗原在通过相关系数测量预测外周区和移行区癌体积方面的局限性。
J Urol. 1996 Jan;155(1):232-7.
9
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.局限性前列腺癌的区域起源不影响根治性前列腺切除术后的生化复发率。
Eur Urol. 2007 Apr;51(4):949-55; discussion 955. doi: 10.1016/j.eururo.2006.07.008. Epub 2006 Jul 28.
10
Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.对于患有大体积癌症的男性,术前血清前列腺特异性抗原不能反映根治性前列腺切除术后的生化失败率。
J Urol. 2000 Nov;164(5):1596-600.

引用本文的文献

1
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.前列腺癌:遗传学、当前生物标志物和个体化治疗的综述。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70016. doi: 10.1002/cnr2.70016.
2
Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion.扩散加权成像及受限扩散编辑中的方向和采集间可变性。
Magn Reson Med. 2022 Nov;88(5):2298-2310. doi: 10.1002/mrm.29385. Epub 2022 Jul 21.
3
Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images.
深度学习在多参数磁共振图像中全自动检测、分割和 Gleason 分级前列腺癌。
Sci Rep. 2022 Feb 22;12(1):2975. doi: 10.1038/s41598-022-06730-6.
4
The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic.COVID-19大流行期间泌尿生殖系统癌症不断发展的临床管理
Front Oncol. 2021 Sep 27;11:734963. doi: 10.3389/fonc.2021.734963. eCollection 2021.
5
Optimizing the diagnosis and management of ductal prostate cancer.优化导管前列腺癌的诊断和管理。
Nat Rev Urol. 2021 Jun;18(6):337-358. doi: 10.1038/s41585-021-00447-3. Epub 2021 Apr 6.
6
Making a case "against" focal therapy for intermediate-risk prostate cancer.提出反对针对中危前列腺癌进行聚焦治疗的理由。
World J Urol. 2021 Mar;39(3):719-728. doi: 10.1007/s00345-020-03303-y. Epub 2020 Jun 11.
7
Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope.前列腺癌中针对雄激素受体信号轴的疗法:进展、挑战与希望
Cancers (Basel). 2019 Dec 23;12(1):51. doi: 10.3390/cancers12010051.
8
Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer.定量表观扩散系数数据的添加对 PI-RADS v2 评分系统检测临床显著前列腺癌的诊断性能的影响。
World J Urol. 2020 Apr;38(4):981-991. doi: 10.1007/s00345-019-02827-2. Epub 2019 Jun 7.
9
Genetics and biology of prostate cancer.前列腺癌的遗传学和生物学
Genes Dev. 2018 Sep 1;32(17-18):1105-1140. doi: 10.1101/gad.315739.118.
10
Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology.前列腺癌超声成像的准确验证:成像与组织病理学配准中的挑战综述
J Ultrasound. 2018 Sep;21(3):197-207. doi: 10.1007/s40477-018-0311-8. Epub 2018 Jul 30.